(445) Outcomes of Heart Transplant Recipients That Had a Percutaneous Coronary Intervention

PurposeCoronary allograft vasculopathy (CAV) contributes to long-term mortality after heart transplantation (HT). A selected population of patients undergo percutaneous coronary intervention (PCI) for focal lesions. We sought investigate the real-life outcomes PCI treatment CAV.MethodsIn a retrospective cohort study, we analyzed included in 2011-2019 Nationwide Readmissions Database (NRD). identified adult with history HT who underwent and their baseline characteristics based on ICD-9-CM ICD10-CM codes. performed multivariable logistic regression analysis adjusted age, sex, relevant comorbidities, hospital bed size assess predictors readmissions mortality.ResultsWe 726 PCI. Patients had mean age 59.3 years, 76.2% were male. In this cohort, 111 (16.1%) readmitted within 30 days 33 (4.5%) died during index hospitalization. Table 1 contains characteristics. In-hospital complications AKI (24.1%), bleeding requiring transfusion (2.5%), stroke (0.9%), AMI (27.9%), need MCS (7.9%), cardiac arrest (4.1%). End-stage renal disease (OR=2.63, CI 1.25-5.54, p=0.012) COPD (OR=3.25, 1.64-6.46, p=0.001) independent 30-day readmissions, whereas arrhythmias (OR=2.11, 1.23-3.61, p=0.007), ESRD (OR 1.61, 1.13-2.30, p =0.009), in-hospital mortality. The 180-day readmission rate post was 32.5%.ConclusionOver 9 relatively low number Hospitalizations associated significant morbidity End stage as predictor poor outcomes. Coronary CAV. 32.5%. Over